Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 12/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 2/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.35 |
| ▸ | HTT | P42858 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17934495 | 1.00 | KDM4E (0.43) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL15923553 | 1.00 | KDM4E (0.43) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL2979672 | 0.87 | KDM4E (0.41) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL1012047 | 0.85 | KDM4E (0.48) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL2513013 | 0.85 | KDM4E (0.40) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL13346630 | 0.84 | KDM4E (0.39) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL13346629 | 0.84 | KDM4E (0.39) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL13346627 | 0.84 | KDM4E (0.39) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL13346631 | 0.84 | KDM4E (0.39) | KDM4EALDH1A1TSHRTDP1LMNA | |
| SCHEMBL5604286 | 0.84 | KDM4E (0.39) | KDM4EALDH1A1TSHRTDP1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 544 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-112679642-B | Cycloolefin copolymer and preparation method thereof | 广东华锦达新材科技有限公司 | 2023-05-12 | — | — | CN | claimed |
| CN-113372478-B | Aldehyde group functionalized cycloolefin-ethylene copolymer and preparation method thereof | 万华化学集团股份有限公司 | 2022-07-15 | — | — | CN | claimed |
| CN-113372478-A | Aldehyde group functionalized cycloolefin-ethylene copolymer and preparation method thereof | 万华化学集团股份有限公司 | 2021-09-10 | — | — | CN | claimed |
| JP-4722828-B2 | — | — | 2011-07-13 | — | — | JP | claimed |
| CN-1777624-B | Vinyl addition polycyclic olefin polymers prepared with non-olefinic chain transfer agents and uses thereof | PROMERUS LLC | 2011-05-04 | — | — | CN | claimed |
| EP-1597287-B1 | VINYL ADDITION POLYCYCLIC OLEFIN POLYMERS PREPARED WITH NON-OLEFINIC CHAIN TRANSFER AGENTS AND USES THEREOF | PROMERUS LLC (US) | 2010-05-05 | — | — | EP | claimed |
| US-7674847-B2 | Vinyl addition polycyclic olefin polymers prepared with non-olefinic chain transfer agents and uses thereof | PROMERUS LLC (US) | 2010-03-09 | — | — | US | claimed |
| EP-1597287-A4 | VINYL ADDITION POLYCYCLIC OLEFIN POLYMERS PREPARED WITH NON-OLEFINIC CHAIN TRANSFER AGENTS AND USES THEREOF | PROMERUS LLC (US) | 2008-12-17 | — | — | EP | claimed |
| US-20070066775-A1 | Vinyl addition polycylic olefin polymers prepared using non-olefinic chain transfer agents and uses thereof | PROMERUS LLC (US) | 2007-03-22 | — | — | US | claimed |
| CN-1777624-A | Vinyl addition polycyclic olefin polymers prepared with non-olefinic chain transfer agents and uses thereof | PROMERUS LLC (US) | 2006-05-24 | — | — | CN | claimed |
| EP-1597287-A2 | VINYL ADDITION POLYCYCLIC OLEFIN POLYMERS PREPARED WITH NON-OLEFINIC CHAIN TRANSFER AGENTS AND USES THEREOF | Promerus LLC (US) | 2005-11-23 | — | — | EP | claimed |
| US-20040229157-A1 | Vinyl addition polycyclic olefin polymers prepared with non-olefinic chain transfer agents and uses thereof | PROMERUS LLC | 2004-11-18 | — | — | US | claimed |
| WO-2004076495-A2 | VINYL ADDITION POLYCYCLIC OLEFIN POLYMERS PREPARED WITH NON-OLEFINIC CHAIN TRANSFER AGENTS AND USES THEREOF | PROMERUS LLC (US) | 2004-09-10 | — | — | WO | claimed |
| US-6258508-B1 | PHOTORESISTS | KOREA ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2001-07-10 | — | — | US | claimed |
| JP-62226943-A | — | — | None | — | — | JP | disclosed |
| US-12630738-B2 | In-mold coating crosslinkers, compositions, systems, processes and articles | RED SPOT PAINT & VARNISH CO., INC. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | OSMO LABS PBC (US) | 2026-03-19 | — | — | US | disclosed |
| EP-1085379-A1 | Radiation-sensitive resin composition | JSR Corporation (JP) | 2001-03-21 | — | — | EP | disclosed |
| EP-1057859-A2 | Radiation sensitive resin composition and use of the same in an interlaminar insulating film | JSR Corporation (JP) | 2000-12-06 | — | — | EP | disclosed |
| JP-S62226943-A | NORBORNENE DERIVATIVE HAVING SUBSTITUTED ETHYL GROUP AND PERFUMERY COMPOSITION CONTAINING SAME | NIPPON PETROCHEM CO LTD | 1987-10-05 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630738-B2 | In-mold coating crosslinkers, compositions, systems, processes and articles | UROD, DUOX1, PDCD2L | KDM4E 1615/4885ALDH1A1 666/4885TSHR 4843/4885 |
| US-20260078079-A1 | FRAGRANCE AND FLAVOR COMPOSITIONS COMPRISING NORBORNANE AND NORBORNENE DERIVATIVES | CBR1, CBR3, TAS2R1 | KDM4E 4643/4885ALDH1A1 804/4885TSHR 1119/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.